Publications

Publications

WHO/Victor Garstea
© Credits

Latest publications

All →
Children and adolescent health country profiles: a healthy start for a healthy life

This publication introduces the child and adolescent health country profiles developed for the WHO European Region under the joint WHO–UNICEF strategy...

Assistive technology financing in Tajikistan: policy suggestions for affordable access

This technical report presents financing options to advance Tajikistan’s assistive technology (AT) sector towards universal health coverage (UHC)....

Increasing childhood vaccination among rural/semi-urban low socioeconomic communities in Romania: insights and recommended actions

Immunization is fundamental to a strong health system and timely routine immunization is essential for all children. Romania has experienced a steady decline...

Mental health and well-being in prisons and other detention centres: report of the International Prison Health Conference, Amsterdam, Netherlands (Kingdom of the), 18–19 April 2024

The 2024 International Prison Health Conference, held on 18–19 April in Amsterdam under the WHO Health in Prisons Programme and cohosted by Dutch...



Latest documents

All →

Tuberculosis and malnutrition factsheet

Overview

TB remains an important cause of mortality and morbidity in the WHO European Region and worldwide. Rates of drug-resistant TB are increasing globally. Malnutrition has significant interactions with the TB disease process and may be an important therapeutic target. There is a bidirectional relationship between TB and malnutrition: malnourished individuals are at greater risk of contracting TB, and TB is a catabolic disease that can cause or exacerbate malnutrition. TB patients who are malnourished experience poorer outcomes, which are more pronounced in those with RR/MDR-TB. Malnutrition impairs immune system function in multiple ways, and this may underpin some of the observed relationships. Furthermore, malnutrition can influence how drugs are absorbed and processed, causing treatment failure and downstream effects on treatment toxicity rates in TB patients.

WHO Team
Special Initiative on NCDs and Innovation (SNI)
Number of pages
10